Non-alcoholic fatty liver disease and the interface between primary and secondary care.

Tsochatzis, Emmanuel A and Newsome, Philip N (2018) Non-alcoholic fatty liver disease and the interface between primary and secondary care. The lancet. Gastroenterology & hepatology, 3 (7). pp. 509-517. ISSN 2468-1253.

Full text not available from this repository.
Official URL: https://www.thelancet.com/journals/langas/home

Abstract

Non-alcoholic fatty liver disease (NAFLD) has a prevalence of 25-30% in unselected populations and has become the main reason for referrals to hepatology services. From the perspective of liver disease, NAFLD has a high prevalence but low severity. Screening studies in people at risk for NAFLD have shown a prevalence of advanced fibrosis of 5%, which underlines the need for robust pathways for risk stratification in primary care, with subsequent referrals as required. In this Review, we discuss the interface between primary and secondary care with regards to risk stratification and management of patients with NAFLD. We focus on selected issues of epidemiology and natural history and discuss the burden of disease in primary care, the evidence on screening for NAFLD, the rationale for testing for advanced fibrosis, and the optimal management of the disease in primary care.

Item Type: Article
Subjects: WJ Urogenital system. Urology
Divisions: Planned IP Care > Gastroentrology
Related URLs:
Depositing User: Stephen Yates
Date Deposited: 22 Mar 2019 09:10
Last Modified: 22 Mar 2019 09:10
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/1900

Actions (login required)

View Item View Item